🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07535021
Recruiting Not applicable

The Effect of Mandala Art Therapy, Psychological Resilience, Coping With Cancer, Colorectal Cancer Surgery

NCT07535021 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-01
Last updated
2026-04-16

Condition(s) studied

Colorectal CancerCoping, CognitivePsychological Well-Being

Investigational drug(s) / intervention(s)

Mandala art therapyrutine service operation

Mandala art therapy: Mandala art therapy was applied to the experimental group in the postoperative period.

rutine service operation: No additional intervention will be made to the control group; only data collection forms will be applied.

Study summary

The aim of this study is to evaluate the effects of mandala art therapy on psychological resilience and coping with cancer in patients undergoing colorectal cancer surgery.

This study was conducted as a randomized controlled trial with a pre-test-post-test design, including intervention and control groups. The study will be conducted between January 2026 and December 2026 with patients undergoing colorectal cancer surgery. The G.power 3.1.9.7 program was used for sample size calculation. The sample size was determined as 28 individuals in each group, considering equal sample sizes in the experimental and control groups, a 95% confidence interval (type I error 5%), and statistical power of 80% (type II error 20%) with an effect size of d=0.50. However, considering a possible 20% data loss, 35 individuals will be included in each group, resulting in a total sample size of 70 individuals.

Sample selection will be made using sequential sampling according to inclusion criteria. Patients will then be randomly assigned to the experimental group (A) and the control group (B) using block randomization (four-block). First, 15 blocks of four, such as AABB, ABAB, ABBA, BBAA, BABA, BAAB, etc., will be prepared by the researcher and statistician. Individuals will then be divided into two groups according to the prepared list; this process will be repeated continuously until the sample size is complete.

Three data collection forms were used. SPSS 22.00 software package was used for data analysis. Skewness and kurtosis analyses were performed to determine the normality of the data distribution. Frequency (n) and percentage (%) distributions were calculated to determine the sociodemographic and clinical characteristics of the participants. Independent samples t-test was used to determine the mean differences between two independent groups, dependent samples t-test was used to compare pre- and post-intervention measurements, and repeated measures one-way analysis of variance (ANOVA) was used. Cohen's d effect size was calculated to evaluate the significance of the difference between groups in terms of the intervention. The statistical significance level was accepted as p\<0.05.

Eligibility

Sex
ALL
Min age
18 Years
Max age
74 Years
Healthy volunteers
Accepted
Inclusion Criteria: * To communicate, * Aged 18 or older, * Agreed to participate * Scheduled for colorectal cancer surgery. * No physical disability of the upper extremities, * no visual problems, * no history of psychotic drug use, * pain intensity and fatigue level ≤3 points according to VAS-10 before MST application, * will be hospitalized for 3 days postoperatively, Exclusion Criteria: * Over 74 years old, * has not completed mandala art therapy application, * is not compliant with the application, * has a history of previous psychiatric diagnosis.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sivas Cumhuriyet University Sivas Turkey (Türkiye) Recruiting

More Cumhuriyet University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07535021 on ClinicalTrials.gov ↗ ← All trials in Turkey